Market News

Trulieve-affiliated dispensaries across the state will host event activations on Saturday, January 29

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States is hosting a statewide grand re-branding celebration spanning all Trulieve-affiliated Pennsylvania retail locations on Saturday, Jan. 29 . Trulieve invites registered medical marijuana patients and caregivers to join the celebration at each of its affiliated medical marijuana dispensaries across the state.

Trulieve logo (PRNewsfoto/Trulieve Cannabis Corp.)

While all locations will be a part of the celebration, the Company will host its marquee event and ribbon cutting at Chamounix Ventures, LLC d/b/a Trulieve (300 Packer Ave, Philadelphia, PA ). There will be two additional ribbon cuttings with similar re-branding event activations at SMPB Retail, LLC d/b/a Trulieve  (3225 N 5th Street, Reading, PA ) and Keystone Relief Centers d/b/a Trulieve (200 Adios Dr. Suite 20, Washington, PA ).

"As a cornerstone market for Trulieve, we are proud to serve Pennsylvania's patient population with an unrivaled selection of the highest-quality medical marijuana products at all of our affiliated dispensaries across the state," said Kim Rivers , Chief Executive Officer of Trulieve. "Over the last year, our retail team's unwavering commitment to patients has created a growing community of "Trulievers" in Pennsylvania , where we've rebranded each of our affiliated dispensaries under the Trulieve banner. We look forward to celebrating with our extended Trulieve community and welcoming patients in our affiliated dispensaries for years to come."

Trulieve's statewide celebration commemorates the rebranding of its affiliated retail dispensaries, located in Camp Hill , Cranberry Township , Devon , Harrisburg , Johnstown , King of Prussia , Pittsburgh , Philadelphia , Reading , Scranton , Washington , Whitehall , York and Zelienople .

To find a location or to learn how to become a registered patient, visit Trulieve.com , follow us on Instagram at trulieve_pa or connect with Trulieve PA on Facebook.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve

Investor Contact
Christine Hersey , Director of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Rob Kremer , Executive Director of Corporate Communications
+1 (404) 218-3077
Robert.Kremer@Trulieve.com

MATTIO Communications
Trulieve@Mattio.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-celebrates-completion-of-statewide-retail-rebrand-in-pennsylvania-301467418.html

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2022/25/c9095.html

News Provided by Canada Newswire via QuoteMedia

TCNNF,TRUL:CNX

Cresco Labs Announces the Expiration of the HSR Act Waiting Period for the Proposed Acquisition of Columbia Care

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) ("Cresco Labs" or the "Company") and Columbia Care Inc. (NEO:CCHW) (CSE:CCHW) (OTCQX:CCHWF) (FSE:3LP) ("Columbia Care"), today announced the expiration of the 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") in connection with Cresco Labs' previously announced proposed acquisition of Columbia Care (the "Transaction").

"Completion of the HSR milestone is a major step towards closing the acquisition of Columbia Care. We've been concurrently working on our divestiture process and working with our state regulators to align with our previously disclosed estimated closing timeline of year-end," said Charles Bachtell, CEO of Cresco Labs. "With this acquisition, we will be able to leverage our best selling cannabis portfolio 1 across the most exciting footprint in cannabis and further develop our leading positions with exposure to all ten of the largest projected revenue states in 2025, according to BDSA."

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
The Greenrose Holding Company to Hold First Quarter 2022 Conference Call on May 16, 2022 at 5:30 p.m. ET

The Greenrose Holding Company to Hold First Quarter 2022 Conference Call on May 16, 2022 at 5:30 p.m. ET

The Greenrose Holding Company Inc. (OTC: GNRS, GNRSW) ("Greenrose" or the "Company"), a multi-state grower and producer of cannabis brands and products, will hold a conference call on Monday, May 16, 2022 at 5:30 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2022. The Company will provide its financial results in a press release prior to the conference call.

Greenrose management will host the conference call, followed by a question and answer session.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Canopy Growth to Report Fourth Quarter and Fiscal Year 2022 Financial Results on May 27, 2022

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the fourth quarter and fiscal year 2022 ended March 31, 2022 before financial markets open on May 27, 2022 .

Canopy Growth to Report Fourth Quarter and Fiscal Year 2022 Financial Results on May 27, 2022 (CNW Group/Canopy Growth Corporation)

Following the release of its fourth quarter and fiscal year 2022 financial results, Canopy Growth will host an audio webcast with David Klein , CEO and Judy Hong , CFO at 10:00 AM Eastern Time on May 27, 2022.

Beginning this quarter, the Company will be using a question and answer platform developed by Say Technologies to enhance engagement with its shareholders, allowing verified retail and institutional shareholders to submit and upvote questions. Management will address a limited number of questions relating to Canopy Growth's business and financial results during the Q&A portion of the conference call. The platform will open on May 20, 2022 , at 10:00 a.m. ET and close on May 26, 2022 , at 10:00 a.m. ET .

Shareholders can submit questions, after the platform opens, by visiting https://app.saytechnologies.com/canopy-growth-corporation-2022-q4 .

Webcast Information

A live audio webcast will be available at:

https://produceredition.webcasts.com/starthere.jsp?ei=1540225&tp_key=a04693a9b2

Replay Information

A replay will be accessible by webcast until 11:59 PM ET on August 25, 2022 , at:

https://produceredition.webcasts.com/starthere.jsp?ei=1540225&tp_key=a04693a9b2

About Canopy Growth Corporation
Canopy Growth (TSX: WEED ) (NASDAQ: CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany . Through our award-winning Tweed and Tokyo Smoke banners, we reach our adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada , the United States , and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional hemp derived CBD products to the United States through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information visit www.canopygrowth.com .

Notice Regarding Forward Looking Statements
This press release contains "forward-looking statements" and "forward-looking information" within the meaning of applicable U.S. and Canadian securities laws (collectively, "forward-looking statements"), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments. These forward-looking statements are generally identified by their use of such terms and phrases as "intend," "goal," "strategy," "estimate," "expect," "project," "projections," "forecasts," "plans," "seeks," "anticipates," "potential," "proposed," "will," "should," "could," "would," "may," "likely," "designed to," "foreseeable future," "believe," "scheduled" and other similar expressions. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Forward‐looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those forward‐looking statements and the forward‐looking statements are not guarantees of future performance. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. A discussion of some of the material factors applicable to Canopy Growth Corporation ("Canopy") can be found under the section entitled "Risk Factors" in Canopy's Annual Report on Form 10-K for the year ended March 31, 2021 , filed with the Securities and Exchange Commission and with applicable Canadian securities regulators, as such factors may be further updated from time to time in its periodic filings with the Securities and Exchange Commission and with applicable Canadian securities regulators, which can be accessed at www.sec.gov/edgar and www.sedar.com , respectively. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the filings. Any forward‐looking statement included in this press release is made as of the date of this press release and, except as required by law, Canopy disclaims any obligation to update or revise any forward‐ looking statement. Readers are cautioned not to put undue reliance on any forward‐looking statement. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/canopy-growth-to-report-fourth-quarter-and-fiscal-year-2022-financial-results-on-may-27-2022-301546704.html

SOURCE Canopy Growth Corporation

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2022/13/c6398.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Avicanna Reports Q1 2022 Financial Statement and Management Change

Avicanna Reports Q1 2022 Financial Statement and Management Change

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS

Avicanna Inc. (" Avicanna " or the " Company ") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, is pleased to announce the filing of its interim financial statements for the three-month period ending March 31, 2022 (" Q1 2022 ") and the transition of the role of Chief Financial Officer.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

TerrAscend Reports First Quarter 2022 Financial Results

TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today reported its financial results for the first quarter ending March 31, 2022 . All amounts are expressed in U.S. dollars unless indicated otherwise and are prepared under U.S. Generally Accepted Accounting principles (GAAP).

First Quarter 2022 Financial Highlights

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×